These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8913443)

  • 1. Reduced accumulation of drug in Candida krusei accounts for itraconazole resistance.
    Venkateswarlu K; Denning DW; Manning NJ; Kelly SL
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2443-6. PubMed ID: 8913443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition and interaction of cytochrome P450 of Candida krusei with azole antifungal drugs.
    Venkateswarlu K; Denning DW; Kelly SL
    J Med Vet Mycol; 1997; 35(1):19-25. PubMed ID: 9061581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of fluconazole resistance in Candida krusei.
    Orozco AS; Higginbotham LM; Hitchcock CA; Parkinson T; Falconer D; Ibrahim AS; Ghannoum MA; Filler SG
    Antimicrob Agents Chemother; 1998 Oct; 42(10):2645-9. PubMed ID: 9756770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide expression profiling reveals genes associated with amphotericin B and fluconazole resistance in experimentally induced antifungal resistant isolates of Candida albicans.
    Barker KS; Crisp S; Wiederhold N; Lewis RE; Bareither B; Eckstein J; Barbuch R; Bard M; Rogers PD
    J Antimicrob Chemother; 2004 Aug; 54(2):376-85. PubMed ID: 15201233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of mutations in the cytochrome P450 14alpha-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans.
    Marichal P; Koymans L; Willemsens S; Bellens D; Verhasselt P; Luyten W; Borgers M; Ramaekers FCS; Odds FC; Vanden Bossche H
    Microbiology (Reading); 1999 Oct; 145 ( Pt 10)():2701-2713. PubMed ID: 10537192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluconazole resistance in Candida glabrata.
    Hitchcock CA; Pye GW; Troke PF; Johnson EM; Warnock DW
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1962-5. PubMed ID: 8239613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Origin of differences in susceptibility of Candida krusei to azole antifungal agents.
    Marichal P; Gorrens J; Coene MC; Le Jeune L; Vanden Bossche H
    Mycoses; 1995; 38(3-4):111-7. PubMed ID: 7477085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of fluconazole-resistant clinical isolates of Candida spp. to echinocandin LY303366, itraconazole and amphotericin B.
    Cuenca-Estrella M; Mellado E; Díaz-Guerra TM; Monzón A; Rodríguez-Tudela JL
    J Antimicrob Chemother; 2000 Sep; 46(3):475-7. PubMed ID: 10980178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifungal drug resistance in pathogenic fungi.
    Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D
    Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of itraconazole resistance in Candida dubliniensis.
    Pinjon E; Moran GP; Jackson CJ; Kelly SL; Sanglard D; Coleman DC; Sullivan DJ
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2424-37. PubMed ID: 12878500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterologous Expression of Full-Length Lanosterol 14α-Demethylases of Prominent Fungal Pathogens Candida albicans and Candida glabrata Provides Tools for Antifungal Discovery.
    Keniya MV; Ruma YN; Tyndall JDA; Monk BC
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of an azole-resistant Candida glabrata isolate.
    vanden Bossche H; Marichal P; Odds FC; Le Jeune L; Coene MC
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2602-10. PubMed ID: 1482129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new triazole, voriconazole (UK-109,496), blocks sterol biosynthesis in Candida albicans and Candida krusei.
    Sanati H; Belanger P; Fratti R; Ghannoum M
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2492-6. PubMed ID: 9371355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical applicability of antifungal susceptibility testing on non-Candida albicans species in hospitalized patients.
    Wong-Beringera A; Hindler J; Brankovic L; Muehlbauer L; Steele-Moore L
    Diagn Microbiol Infect Dis; 2001 Jan; 39(1):25-31. PubMed ID: 11173188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of the heterologously expressed human lanosterol 14alpha-demethylase (other names: P45014DM, CYP51, P45051) and inhibition of the purified human and Candida albicans CYP51 with azole antifungal agents.
    Lamb DC; Kelly DE; Waterman MR; Stromstedt M; Rozman D; Kelly SL
    Yeast; 1999 Jun; 15(9):755-63. PubMed ID: 10398344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidrug Transporters and Alterations in Sterol Biosynthesis Contribute to Azole Antifungal Resistance in Candida parapsilosis.
    Berkow EL; Manigaba K; Parker JE; Barker KS; Kelly SL; Rogers PD
    Antimicrob Agents Chemother; 2015 Oct; 59(10):5942-50. PubMed ID: 26169412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibility of 115 isolates of Candida to amphotericin B, fluconazole and itraconazole.
    Mallié M; Bastide JM
    Drugs Exp Clin Res; 1996; 22(6):301-7. PubMed ID: 9034756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole.
    Martín E; Parras P; Lozano MC
    Chemotherapy; 1992; 38(5):335-9. PubMed ID: 1337508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to fluconazole and cross-resistance to amphotericin B in Candida albicans from AIDS patients caused by defective sterol delta5,6-desaturation.
    Kelly SL; Lamb DC; Kelly DE; Manning NJ; Loeffler J; Hebart H; Schumacher U; Einsele H
    FEBS Lett; 1997 Jan; 400(1):80-2. PubMed ID: 9000517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro activity of D0870, a new triazole antifungal drug, in comparison with fluconazole and itraconazole against Aspergillus fumigatus and Candida krusei.
    Venkateswarlu K; Denning DW; Kelly SL
    J Antimicrob Chemother; 1997 Jun; 39(6):731-6. PubMed ID: 9222042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.